IDRA-008

N/A

Report date: 2023/02/18 23:49:11

Base Information

Drug NameIDRA-008
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGene silencing
TargetsNot applicable
Therapy Area/IndicationsLipodystrophyHyperlipoproteinemia Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAceragen Inc
Active IndicationsN/A
Inactive IndicationsLipodystrophyHyperlipoproteinemia Type I

Other Information

ATC CodeN/A
Related LinksN/A